Last10K.com

Forward Pharma As (FWP) SEC Filing 20-F Annual report for the fiscal year ending Sunday, December 31, 2017

Forward Pharma As

HISTORY TOOLS
CIK: 1604924 Ticker: FWP

View differences made from one year to another to evaluate Forward Pharma As's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Forward Pharma As.

Continue

Assess how Forward Pharma As's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Forward Pharma As's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Statement Of Cash Flows
Consolidated Statement Of Changes In Shareholders' Equity
Consolidated Statement Of Financial Position
Consolidated Statement Of Other Comprehensive Income (loss)
Consolidated Statement Of Profit Or Loss
Basis Of Preparation (details)
Basis Of Preparation (policies)
Basis Of Preparation (tables)
Basis Of Presentation
Capital Structure And Financial Risk And Related Items
Capital Structure And Financial Risk And Related Items (tables)
Capital Structure And Financial Risk And Related Items - Equity And Capital Management (details)
Capital Structure And Financial Risk And Related Items - Financial Assets (details)
Capital Structure And Financial Risk And Related Items - Financial Liabilities (details)
Capital Structure And Financial Risk And Related Items - Financial Risk Factors (details)
Corporate Information
Corporate Information (details)
Operating Assets And Liabilities
Operating Assets And Liabilities (tables)
Operating Assets And Liabilities - Accrued Liabilities (details)
Operating Assets And Liabilities - Other Receivables (details)
Operating Assets And Liabilities - Prepaid Expenses (details)
Operating Assets And Liabilities - Summary Of Depreciation Expense (details)
Operating Assets And Liabilities - Summary Of Equipment (details)
Other Disclosures
Other Disclosures (tables)
Other Disclosures - Commitments (details)
Other Disclosures - Contingent Liabilities (details)
Other Disclosures - Related Party Disclosures (details)
Results For The Year
Results For The Year (tables)
Results For The Year - Deferred Share Activity (details)
Results For The Year - Government Grant And Staff Costs (details)
Results For The Year - Income Tax - Components Of Income Tax (details)
Results For The Year - Income Tax - Deferred Tax (details)
Results For The Year - Net Income (loss) Per Share (details)
Results For The Year - Options And Warrants And The Weighted Average Exercise (details)
Results For The Year - Range Of Exercise (details)
Results For The Year - Share- Based Payment (details)
Ticker: FWP
CIK: 1604924
Form Type: 20-F Annual Report
Accession Number: 0001047469-18-003354
Submitted to the SEC: Mon Apr 30 2018 4:37:31 PM EST
Accepted by the SEC: Mon Apr 30 2018
Period: Sunday, December 31, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/fwp/0001047469-18-003354.htm